Atom Investors’s Organon & Co OGN Stock Holding History

Atom Investors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,919	Closed	-$684K	–	739
2025 Q1	$684K	Sell	45,919 -22,565	-33%	-$347K	0.08%	261
2024 Q4	$1.02M	Buy	+68,484	New	+$1.12M	0.13%	236

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Atom Investors's OGN Position: Q2 2025 in Review

Atom Investors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 45,919 shares — an estimated $684K sold.

Atom Investors first reported a position in OGN in Q4 2024 and held it in 2 quarters. The position peaked at $1.02M in Q4 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

Atom Investors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
Atom Investors sold 45,919 Organon & Co shares in Q2 2025, an estimated $684K.
Atom Investors first reported a position in Organon & Co in Q4 2024 and held it in 2 quarters.
Atom Investors's Organon & Co position peaked at $1.02M in Q4 2024.
695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Atom Investors's 13F filing for Q2 2025, filed 14 Aug 2025.